empty
 

P3pharmacy & Numark: Emerging from Covid - The Welsh perspective

12 May/7PM

Over three months, P3pharmacy, in partnership with Numark, is looking at how community pharmacies across the UK will re-emerge from Covid.

In a series of three regional webcasts, we discuss how community pharmacy will use the experiences of the pandemic, which has sped up some developments and delayed others, to shape the future. What things should community pharmacy be prioritising, and what support will pharmacists on the front line need for working as an increasingly integrated and integral part of primary care in the devolved health care systems of the UK?

The series kicked off on April 14 when Community Pharmacy Scotland chief executive Harry McQuillan and a panel of community pharmacists in Scotland joined us to talk about how the aligned ambitions of community pharmacy and Government are shaping developments.

Now register for the Welsh perspective. More details will follow.

On demand webcasts

Watch webcasts that have previously ran:

P3pharmacy & Numark: Emerging from Covid - The Scottish perspective

Automation for the Future – How the Right Robot Can Support Your Pharmacy

The Role of Community Pharmacy in Tackling Antimicrobial Resistance - In Partnership with Difflam

Independent Pharmacy Awards 2020

NHS Reset: A P3pharmacy & Numark in Conversation Webcast

Project Rethink Pharmacy

The Wright Review - What next for LPCs?



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.